Attending JPMorgan Conference & Biotech Showcase
ImmuPharma PLC announced that its CEO, COO, and CSO will attend the JP Morgan Conference and Biotech Showcase in San Francisco from January 12-14, 2026, to engage with global biopharma companies and investors at these premier partnering events.
Select text to share a quote on X · sign in to keep highlights & notes in your IMM notes
| RNS REACH | 6 JANUARY 2026 |
| ImmuPharma PLC | |
| ("ImmuPharma" or the "Company") | |
| IMMUPHARMA AT JP MORGAN CONFERENCE & BIOTECH SHOWCASE™ | |
| 12-14 January 2026 | San Francisco |
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces that Tim McCarthy, CEO, Dr Tim Franklin, COO, and Dr Sebastien Goudreau, CSO, will be attending both the JP Morgan Conference and the Biotech Showcase from 12-14 January 2026, in San Francisco, USA.
The JP Morgan conference and Biotech Showcase are annual premier partnering events, designed to provide biotechnology companies with the opportunity to present to and connect with global Biopharma companies and investors.
About JP Morgan Healthcare Conference
The J.P. Morgan Healthcare Conference 2026 is the industry's premier investment symposium. It draws over 8,000 attendees including pharma/biotech executives, investors, startups, analysts, and policymakers for strategic discussions and dealmaking.
About Biotech Showcase
Biotech Showcase in San Francisco is an investor‑focused partnering conference held each January alongside JP Morgan Healthcare Conference week. It is designed mainly for private and micro‑ to mid‑cap biotech companies to meet global investors and pharma executives.
About Reach announcements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.